Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
  • C12P7/00—Preparation of oxygen-containing organic compounds
  • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
  • C12P7/56—Lactic acid
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
  • C12N1/14—Fungi; Culture media therefor
  • C12N1/16—Yeasts; Culture media therefor
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
  • C12N15/09—Recombinant DNA-technology
  • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
  • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
  • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
  • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
  • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/0004—Oxidoreductases (1.)
  • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
  • C12P7/00—Preparation of oxygen-containing organic compounds
  • C12P7/62—Carboxylic acid esters
  • C12P7/625—Polyesters of hydroxy carboxylic acids
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
  • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
  • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
  • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
  • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
  • Y02E50/00—Technologies for the production of fuel of non-fossil origin
  • Y02E50/10—Biofuels, e.g. bio-diesel
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
  • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
  • Y02P20/00—Technologies relating to chemical industry
  • Y02P20/50—Improvements relating to the production of bulk chemicals
  • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Definitions

• Lactic acid has wide industrial applicability including uses in chemical processing and synthesis, cosmetics, pharmaceuticals, plastics, and food production. Most industrial scale processes for making lactic acid are fermentation processes. Various lactic acid-producing bacteria have been used in those fermentation processes.
• Recombinant yeast potentially can provide several advantages over bacterial fermentations. Some yeast strains are more resistant to higher temperatures. This potentially allows for higher temperature fermentations, which can translate to faster rates of fermentations. Better resistance to high temperature can make it easier to purge a fermentation medium of contaminating microbes, as the medium can simply be heated to a temperature at which the unwanted species die off but the desired species can tolerate. Lactic acid-producing bacteria such as lactobacilli require a complex fermentation medium in order to produce efficiently. The complexity of the fermentation medium increases raw materials costs and makes it more difficult and expensive to separate the lactic acid from the medium. Using recombinant yeast offers the possibility of reducing costs by using a simplified fermentation medium.
• Porro and coworkers have attempted to engineer a lactic-acid producing yeast by inserting an exogenous LDH (lactate dehydrogenase) gene into yeast cells from the species S. cerevisiae, K. lactic, T. delbrueckii and Z. bailii, and disrupting the cell's natural pyruvate pathway.
• LDH lactate dehydrogenase
• Rajgarhia and coworkers have created recombinant yeast that exhibits higher yields and productivities than those of Porro. See, for example, WO 00/71738, WO 02/42471 and PCT/US02/16223.
• Rajgarhia's work as described in WO 00/71738 attempts to take advantage of the so-called "Crabtree negative" phenotype exhibited by certain species of yeast.
• the Crabtree effect is defined as the occurrence of fermentative metabolism under aerobic conditions due to the inhibition of oxygen consumption by a microorganism when cultured at high specific growth rates (long-term effect) or in the presence of high concentrations of glucose (short- term effect).
• Crabtree negative phenotypes do not exhibit this effect, and are thus able to consume oxygen even in the presence of high concentrations of glucose or at high growth rates.
• cultures of Crabtree negative microorganisms in theory at least, can be converted from a growth phase to a fermentation (production) phase through manipulation of oxygen supply, hi the presence of significant aeration, the microorganisms grow to produce biomass and CO 2 , whereas under anaerobic conditions, the cells instead ferment the available substrate to produce lactic acid or other fermentation products.
• Figure 1 is a graph illustrating the effect of OUR on glucose consumption, lactic acid production and yield for a certain genetically modified K. marxianus species.
• Figure 2 is a graph illustrating the effect of OUR on glucose consumption, lactic acid production and yield for another genetically modified K. marxianus species.
• this invention is a fermentation process wherein specific oxygen uptake rate is monitored during a production phase of the fermentation process, and at least one operating parameter is controlled in response to the measured oxygen uptake rate.
• this invention is method of conducting a fermentation process in a fermentation medium comprising a fermenting microorganism, a substrate that is fermentable by the microorganism, the fermentation exhibiting a quantity of dissolved oxygen (DO) and a specific oxygen uptake (OUR) during the fermentation, comprising a) measuring the OUR during a production phase of a fermentation; b) adjusting aeration conditions such that the OUR is maintained within a predetermined range while maintaining the DO at less than 1% of the saturation amount during the production phase of the fermentation.
• DO dissolved oxygen
• OUR specific oxygen uptake
• this invention is a process comprising a) determining an optimum range of OUR values at which a fermenting microorganism ferments a carbohydrate to a desired fermentation product; b) growing the microorganism in a medium comprising a carbohydrate that the cell is capable of metabolizing and one or more nutrients, while aerating the medium such that the cells as the cells grow and reproduce, the (DO) in the medium is reduced to less than 1% of the saturation amount and the cells exhibit a specific oxygen uptake rate of at least 10 mmol O 2 /g dry weight of cells/hour (mmol 0 2 /gdw/h); and then c) culturing the microorganism in a buffered medium under fermentation conditions including microaeration conditions sufficient to provide the culture with a specific oxygen uptake rate (OUR) within the optimum range.
• This invention is in another aspect a fermentation process comprising a) growing engineered yeast cells having a disrupted PDC pathway and an exogenous gene which allows the cell to produce a desired fermentation product in a medium comprising a carbohydrate that the cell is capable of metabolizing, while aerating the medium such that the cells as the cells grow and reproduce, the quantity of dissolved oxygen in the medium is reduced to less than 1% of saturation and the cells exhibit a specific oxygen uptake rate of at least 10 mmol 0 2 /g dry weight of cells/hour (mmol 0 2 /gdw/h); and then b) culturing the cells in a buffered medium under fermentation conditions including microaeration conditions sufficient to provide the culture with a specific oxygen uptake rate (OUR) of about 0.8 to about 3.0 mmol 0 2 /gdw/h.
• OUR specific oxygen uptake rate
• microaeration conditions using oxygen uptake rates allows the fermentation process to be optimized, balancing high yields to the desired fermentation product with good production rates.
• OUR measurements can be used to establish and control certain parameters of the fermentation process in order to maintain optimum conditions during a production phase of a fermentation process.
• OUR is the rate of consumption of oxygen (0 2 ) per unit dry weight of the production microorganism per unit time. OUR is conveniently determined from the amount of oxygen that is consumed per unit time, and from the mass of the cells during that time period. Oxygen consumption is conveniently determined by measuring the amount of oxygen supplied to and removed from the fermentation vessel per unit time. OUR is then determined by dividing the oxygen consumption by the mass (dry weight) of the biomass in the broth. The weight of biomass can be determined by taking a sample and measuring the concentration of cells (w/v) and multiplying by the total broth volume. The amount of supplied oxygen can be straightforwardly measured by monitoring aeration rates. The amount of oxygen leaving the fermentation vessel can be measured using various analytical methods, of which mass spectroscopy is particularly useful. The difference between oxygen supplied and oxygen removed is the amount consumed by the cells. OUR is calculated by dividing oxygen consumption by the dry weight of the cells and by unit time. It is conveniently expressed in units of mmol 0 2 /grams cells (dry weight)/hour.
• the invention involves measuring OUR during the production phase of a fermentation, and controlling at least one parameter of the fermentation in response to the measured OUR values.
• the parameter which is controlled in response to the measured OUR will typically be related to the aeration of the fermentation broth, such as aeration rates, agitation rates, aeration gas composition (increasing or decreasing oxygen concentration in the gas, for example), or some other parameter that affects the rate at which the microorganisms in the broth consume oxygen.
• fermenting cells are cultured under various aeration conditions to empirically establish an optimum range of OUR for the particular type of cell.
• the range of OUR that is optimum generally will take into account several factors, of which three tend to be paramount: yield of the desired fermentation product from the fermentation substrate (usually expressed in grams product/grams substrate consumed), specific productivity of the desired fermentation product (usually expressed in weight product/weight dry cell weight/unit time), and substrate consumption rates (usually expressed in weight of substrate consumed/unit time).
• yield of the desired fermentation product from the fermentation substrate usually expressed in grams product/grams substrate consumed
• specific productivity of the desired fermentation product usually expressed in weight product/weight dry cell weight/unit time
• substrate consumption rates usually expressed in weight of substrate consumed/unit time.
• OUR values generally will involve balancing rates with yield to optimize the overall process economics.
• fermentation conditions are selected in a production phase of a fermentation to establish and maintain the OUR within that range.
• OUR is measured during the process and one or more fermentation parameters are controlled so that OUR is maintained within the range.
• the concentration of dissolved oxygen is maintained at approximately zero, which reflects the condition that the cells are consuming oxygen at approximately the same rate at which it is becoming dissolved into the fermentation broth.
• the concentration of dissolved oxygen during the production phase is generally less than 1% of the saturation amount (i.e., the maximum amount that can be dissolved in the broth under the conditions of temperature and pressure that are used).
• dissolved oxygen contents of less than about 10 ⁇ moles/L, more preferably less than about 5 ⁇ moles/L, are suitable. Most preferably, the dissolved oxygen content is essentially zero.
• Dissolved oxygen is conveniently measured using an oxygen electrode with a gas-permeable membrane (Clark electrode), such as that manufactured by h gold and sold by B Braun under part numbers 33182418 or 33182400. Operation at dissolved oxygen contents below the limit of detection of instruments such as these is considered to reflect a dissolved oxygen concentration of approximately zero for purposes of this invention.
• a gas-permeable membrane such as that manufactured by h gold and sold by B Braun under part numbers 33182418 or 33182400. Operation at dissolved oxygen contents below the limit of detection of instruments such as these is considered to reflect a dissolved oxygen concentration of approximately zero for purposes of this invention.
• a microorganism is cultured under different growth and production conditions.
• L the growth phase the microorganism is grown aerobically.
• the cells are grown in a medium that contains water, a carbohydrate that the cell can metabolize in both the growth and the production phases, and various nutrients as described more fully below.
• the aeration conditions are selected such that (1) the cells exhibit a specific oxygen uptake rate (OUR) of at least 10 mmol 0 2 /gdw/h and (2) at the end of the growth phase, and the concentration of dissolved oxygen (DO) in the medium is reduced to less than 1% of the saturation amount while maintaining an OUR of at least 10 mmol 0 2 /gdw/h.
• OUR specific oxygen uptake rate
• the OUR is preferably at least 15 and more preferably at least 18 mmol 0 2 /gdw/h.
• the OUR is most preferably as high as the cells can generate.
• the maximum OUR therefore will depend somewhat on the particular engineered yeast cell that is used. In general, the maximum OUR is expected to be about 20-30 mmol 0 2 /gdw/h.
• K. marxianus cells having a PDC disruption and exogenous LDH gene tend to exhibit a maximum OUR in the range of about 20-22 mmol 0 2 /gdw/h.
• the DO may be and preferably is above zero during most of the growth phase, provided that it is reduced to approximately zero at the end of the phase.
• an excess of oxygen over that required to maintain the required OUR may be introduced into the medium during most of the growth phase, particularly during the period during which the cells experience exponential growth.
• the total oxygen uptake increases during the growth phase as the cells reproduce and biomass accumulates, the total amount of oxygen required to maintain a constant OUR will increase.
• DO may be positive prior to the end of the growth phase, a preferred way of conducting the aeration is to supply an excess of the required oxygen at the beginning and during the exponential stage of the growth phase. As biomass accumulates, the total oxygen consumed by the cells increases to the point where supplied oxygen closely matches that consumed by the cells, and DO drops as a result.
• Constant aeration conditions can therefore be used during the growth phase, if those conditions are selected such that DO drops to zero with the required OUR when the desired amount of biomass has been produced.
• aeration conditions can be varied during the growth phase, provided that the OUR is maintained and DO becomes approximately zero at the end of the growth phase.
• DO drops to approximately zero and the desired amount of biomass has been produced, it is preferred to maintain those aeration conditions (OUR at least 10 mmol 0 2 /gdw/h and DO equal to zero) for a period of time prior to switching to the production phase.
• a suitable period of time is about 15 minutes to 2 hours and a preferred period of time is about 30 to 90 minutes.
• a most preferred period of time is about 45-75 minutes. If the organism is switched to production phase too quickly, the cells tend to exhibit poor production rates. If these aeration conditions are maintained for too long, the cells tend to exhibit poor yields to the desired fermentation product as well as poor production rates.
• microaeration conditions are selected such that the OUR is maintained within a predetermined range, as discussed above.
• Some microorganisms appear to need to metabolize a small amount of oxygen in order to promote overall cell vitality and health. Examples of such organisms include genetically engineered yeast having a PDC disruption, particularly those having an exogenous gene that enables them to produce a particular fermentation product. In fully anaerobic conditions, the rates of substrate consumption and fermentation product production exhibited by these cells are usually very low. In addition, yields of the desired fermentation product suffer. Under microaerobic conditions, at certain OUR values that depend on the particular strain, the cells are able to metabolize the substrate much more rapidly.
• the optimal value of OUR depends somewhat on the particular organism, although in general, the OUR range is from about 0.8 to about 3 mmol 0 2 /gdw/h. Optimal OUR values for a particular organism are easily determined empirically.
• a preferred lower end of the OUR range is about 1.0 mmol 0 2 /gdw/h and more preferably about 1.2 mmol 0 2 /gdw/h.
• a preferred upper end of the OUR range is about 2.5 mmol 0 2 /gdw/h, more preferably about 2.0 mmol 0 2 /gdw/h.
• the OUR exhibited by a culture depends largely on the microorganism itself and the aeration conditions. Aeration conditions affect the amount of oxygen that becomes dissolved in the medium and thus becomes available to the organism. For a given organism, increased OUR is favored by (1) increasing the rate at which oxygen is supplied and (2) the formation of small oxygen bubbles (to improve mass transfer of oxygen molecules into the liquid phase. Small bubble formation is readily achieved through sparging and/or agitation.
• Examples of aeration rates during the growth phase are about at least 0.2 volumes of air/volume of fermentation medium/minute (wm), preferably from about 0.3 to about 2 wm, even more preferably about 0.4 to about 1 wm.
• volumes of about 0.01 to about 0.1 wm, preferably about 0.02 to about 0.75 wm, especially about 0.02 to about 0.5 wm are generally suitable.
• oxygen is used as the aeration gas, volumes will be proportionately smaller.
• Aeration is preferably done under conditions such as sparging that promote the formation of fine gas bubbles. Agitation is preferably maintained, particularly when high OUR values are desired. Typically, aeration rates and agitation conditions are selected together in order to achieve the desired OUR.
• the medium is buffered during the production phase so that the pH is maintained in a range of about 5.0 to about 9.0, preferably about 5.5 to about 7.0.
• Suitable buffering agents are basic materials that neutralize lactic acid as it is formed, and include, for example, calcium hydroxide, calcium carbonate, sodium hydroxide, potassium hydroxide, potassium carbonate, sodium carbonate, ammonium carbonate, ammonia, ammonium hydroxide and the like. In general, those buffering agents that have been used in conventional fermentation processes are also suitable here.
• Temperatures during each of the growth phase and the production phase may range from above the freezing temperature of the medium to about 50°C, although the optimal temperature will depend somewhat on the particular microorganism.
• a preferred temperature, particularly during the production phase is from about 30-45°C.
• the cell is an engineered K. marxianus, it can tolerate relatively high temperatures (such as above 40°C and up to 50°C, especially up to 45°C).
• Another preferred species of cell, C. sonorensis can tolerate temperatures up to about 40°C.
• This temperature range provides for the possibility of conducting the fermentation at such higher temperatures (thereby reducing cooling costs) without a significant loss of productivity.
• Another advantage provided by the good high temperature tolerance is that if the fermentation becomes contaminated with an undesired microorganism, in many cases the undesired microorganism can be selectively killed off by heating the fermentation medium to 40°C or more, especially 45 °C or more, without significantly harming the desired cells of the invention.
• the concentration of cells in the fermentation medium is typically in the range of about 1-150, preferably about 3-10, even more preferably about 3-6 g dry cells/liter of fermentation medium.
• the particular carbohydrates that are used depend on the particular host cell, and whether the host cell has been engineered to metabolize any particular carbohydrate to pyruvate.
• Hexose sugars such as glucose, fructose, glucose oligomers such as maltose, isomaltose, maltotriose, starch and maltodextrins are preferred.
• oligomeric sugars it may be necessary to add enzymes to the fermentation broth in order to digest these to the monomeric sugar.
• An example of a suitable pentose sugar is xylose. Glucose is most preferred.
• acidic fermentation products such as lactic acid are neutralized as they are formed to the corresponding lactate salt.
• Recovery of the acid therefore involves regenerating the free acid. This is typically done by removing the cells and acidulating the fermentation broth with a strong acid such as sulfuric acid.
• a salt by-product is formed (gypsum in the case where a calcium salt is the neutralizing agent and sulfuric acid is the acidulating agent), which is separated from the acid.
• the acid is then recovered through techniques such as liquid- liquid extraction, distillation, absorption, etc., such as are described in T.B. Vickroy, Vol. 3, Chapter 38 of Comprehensive Biotechnology, (ed. M. Moo-Young), Pergamon, Oxford, 1985; R.
• the medium will typically contain nutrients as required by the particular cell, including a source of nitrogen (such as amino acids proteins, inorganic nitrogen sources such as ammonia or ammonium salts, and the like), and various vitamins, minerals and the like.
• a source of nitrogen such as amino acids proteins, inorganic nitrogen sources such as ammonia or ammonium salts, and the like
• various vitamins, minerals and the like including a source of nitrogen (such as amino acids proteins, inorganic nitrogen sources such as ammonia or ammonium salts, and the like), and various vitamins, minerals and the like.
• the process of the invention can be conducted continuously, batch-wise, or some combination thereof.
• the microorganism used in the process of the invention is any that (1) ferments a carbohydrate to a desired fermentation product and (2) ferments more efficiently in the presence of microaerobic conditions than in strictly anerobic conditions.
• Cells of particular interest are certain genetically engineered yeast cells characterized by having (1) a disrupted PDC pathway and (2) at least one functional exogenous gene that enables the cell to produce the desired fermentation product. Suitable such engineered yeast cells are described, for example, in Porro et al., "Development of metabolically engineered Saccharomyces cerevisiae cells for the production of lactic acid", Biotechnol. Prog.
• the cell also preferably exhibits the Crabtree negative phenotype, so that it respires and grows under aeration conditions in the presence of high concentrations of glucose and at high specific growth rates.
• Disrupted it is meant that a native PDC pathway has been altered so that function of the PDC pathway is reduced by at least 90%. Disruption may be achieved by altering the pathway (or one or more genes associated with the pathway) so that it its function is reduced or eliminated, or by removing one or more genes required for the pathway to function. A preferred cell has a deletion of a PDC gene.
• a preferred exogenous gene is a lactate dehydrogenase (LDH) gene.
• the gene is preferably integrated into the genome of the cell.
• the engineered yeast cell may have a single copy or multiple copies of the exogenous LDH gene. It may contain two or more different exogenous LDH genes.
• the gene is integrated into the genome of the cell at the location of a native PDC gene, which is deleted.
• the LDH gene is under the functional control of operative promoter and terminator sequences that are at least 90% homologous to promoter and terminator sequences (particularly PDC promoter and terminator sequences) that are native to the cell.
• Lactobacillus helveticus Pediococcus acidolactici, Lactobacillus casei, Kluyverornyces thermotolerans, Torulaspora delbrueckii, Schizosaccharomyces pombii and B. megaterium are strains that have suitable L-lactate dehydrogenase genes that can be cloned for use in producing the engineering yeast. Two preferred L-lactate dehydrogenase genes are L. helveticus and B. megaterium L-lactate dehydrogenase.
• Lactobacillus helveticus Lactobacillus johnsonii, Lactobacillus bulgaricus, Lactobacillus delbrueckii, lactobacillus plantarum and Lactobacillus pentosus are strains that have suitable D-lactate dehydrogenases that can be cloned for use in the engineered yeast.
• a preferred D-lactate dehydrogenase gene is L. helveticus D-lactate dehydrogenase.
• the engineered cell should exhibit several characteristics.
• the yeast should convert a significant proportion of the carbohydrate to the desired fermentation product (i.e., produce a high yield of product). It should exhibit a high specific productivity, i.e., product a high amount of fermentation product per weight of cell per unit time.
• the cell is preferably also tolerant to high concentrations of the fermentation product. This last property allows the fermentation process to use high concentrations of the starting carbohydrate.
• the fermentation process of the invention provides some or all of the following features:
• the theoretical desired yield is 100%, but practical limits on yields are about 98%.
• the temperature of the fermentation medium affects the high end of readily achievable titers somewhat, as highly concentrated lactic acid solutions (i.e., above about 150 g/liter) tend to become very viscous or gel at temperatures below about 35°C.
• a higher fermentation temperature such as from about 35-50°C, permits higher titers without gelling or undue viscosity build-up.
• volume productivity is expressed as amount of product produced per unit volume of fermentation medium per unit time, typically gram of product/liter medium/hr of time.
• Volume productivities of at least 1.5 g/L/hr, preferably at least 2.0 g/L/hr, more preferably at least 2.5 g/L/hr are desirable.
• maximum productivities tend to up to about 5.0 g/L/hr, and more typically up to about 4.0 g/L/hr. It is highly preferred to conduct the fermentation so that these volume productivities are achieved when the medium pH, temperature, or both are within the ranges described in the preceding paragraph.
• Lactic acid produced according to the invention is useful to produce lactide, a cyclic anhydride of two lactic acid molecules.
• the lactide may be D-lactide (made from two D-lactic acid molecules), L-lactide (made from two L- lactic acid molecules) or D-L-lactide (made from one of each L-lactic acid and D-lactic acid molecules).
• a convenient method of producing lactide from lactic acid is via a polymerization depolymerization method as described in USP 5,142,023 to Gruber et al.
• Lactide in turn, is particularly useful as a monomer for the production of polylactide polymers (PLA) and copolymers. Processes for preparing these polymers are also described in USP 5,142,023 to Gruber et al. Preferred PLA products are melt-stable polymers as described in USP 5,338,822 to Gruber et al.
• the PLA may be semi-crystalline or amorphous.
• An inoculation stock of an engineered yeast cell designated CD 587 is prepared in a 250 ml shake flask containing 100 ml CaC0 3 -buffered (42 g/1) yeast extract (10 g/1) - peptone (20 g/1) medium with 100 g/1 glucose.
• yeast extract 10 g/1) - peptone (20 g/1) medium with 100 g/1 glucose.
• Cell CD 587 is a K. marxianus cell having its PDC gene deleted and an exogenous L. helveticus D-LDH gene integrated into its genome at the site of the deleted PDC gene, under the control of native PDC promoter and terminator sequences. Cell CD 587 and its preparation are described more fully in United States Provisional Application No. 60/384,333, filed May 30, 2002.
• the growth phase is started by inoculating a 3 L fermenter with one 1.5 mL glycerol stock, resulting in an initial OD 6 oo of 0.05.
• the growth phase is run aerobically by continually sparging air at a flow rate of 1.5 L/min (0.5 wm) at a constant stirrer speed of 800 rpm. Growth is continued until the DO is reduced to 5% of air saturation. This coincides with a constant C0 2 concentration in the off-gas.
• OUR is measured by monitoring the amount of air supplied and analyzing the off-gases for oxygen using mass spectrometry.
• the OUR is about 20.8 + 2.5 mmol 0 2 /gdw/hr. Under these conditions, OUR is limited by the ability of the cell to metabolize available oxygen. Final cell density is about 4 g/L.
• Glucose utilization rates (curve 2) increase somewhat as OUR increases from 1.2 to 2.8 and increase substantially at an OUR above 3.0 due to rapid cell respiration.
• the data in Figure 2 suggests that for this strain, an optimum OUR value is in the range of about 0.8 to 2.2, and especially from about 1.0 to about 1.5.
• Example 1 is repeated several times using a strain designated CD 558.
• Strain CD 558 is a K. marxianus cell having its PDC gene deleted. It contains an exogenous L. helveticus D-LDH gene randomly integrated into its genome. The LDH gene is under the control of a S. cerevisiae PGK-1 promoter and S. cerevisiae Gal-10 terminator sequences, i each run, OUR in the growth phase is about 20.5 mmol 0 2 /gdw/hr. Aeration conditions during the production phases are varied from run to run by controlling sparging and stirring rates, in order to vary OUR. OUR values for the different runs are about 0.6, 1.4, 1.7 and 2.2. At a production phase OUR of 1.7, results are as shown in Table 2: Table 2
• Figure 2 illustrates how varying OUR affects production rates and yields.
• yield to lactic acid (curve 1) exhibits a very strong dependence on OUR in the range of 0.7 to 2.2, achieving a maximum when the OUR is around 1.4.
• Lactate production rates (curve 3) similarly peak at that OUR value.
• Glucose consumption rates (curve 2) increase until the OUR is about 2.2 and then flatten out.
• the data in Figure 2 suggests that the optimum OUR is in the range of about 1 to about 1.7, especially about 1.2-1.5.
• Example 1 is repeated three times.
• the first of these runs (3 A) is conducted as described in Example 1, except OUR during the production phase is 2.1 mmol 0 2 /gdw/h.
• the culture is switched to production phase immediately when the DO during the growth phase reaches zero.
• OUR is 1.8 mmol 0 2 /gdw/h, under the same aeration conditions as Example 3A.
• aeration is continued at the end of the growth phase for over 1.5 hours after the DO reaches zero, and the OUR in the production phase is 1.4 mmol 0 2 /gdw/h under the same aeration conditions as Example 3 A. Results are summarized in Table 3.
• OUR is an indicator of the metabolic activity of the microorganism.
• the decrease in OUR when the holding time is zero or exceeds 1.5 hr (relative to that after a holding period of 1 hour) indicates that the microorganism functions less well under those conditions. This is also reflected in a decrease in glucose consumption, lactate production and yields.
• the cells are grown further under aerobic conditions at a temperature of 42°C and pH of 5.5 for about 8 hours.
• DO is reduced from a starting value of 100 down to zero during this time.
• OUR is maintained at 20 mmol 0 2 /gdw/h by aeration with 15 liters/minute of air.
• the culture is maintained at DO zero for one hour.
• the culture is then switched to production phase by reducing aeration to achieve an OUR of 1.5-1.7 mmol 0 2 /gdw/h.
• Additional buffering agent (Ca(OH) 2 is added on demand to maintain the pH at 5.5 + 0.1.
• DO remains at 0% during the production phase.
• the glucose is consumed within 30 hours, providing a lactate titer of 114 g/kg.
• the mean specific glucose consumption rate during the production phase is 1.1 g/g DW.h-1.
• the mean specific lactic acid production rate is 0.8 g/g DW.h-1 with a production yield of 0.76 g lactic acid/g. glucose and an overall yield (including the growth phase) of 0.67 g lactic acid /g glucose.

Landscapes

• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Engineering & Computer Science (AREA)
• Health & Medical Sciences (AREA)
• Zoology (AREA)
• Wood Science & Technology (AREA)
• Genetics & Genomics (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Biotechnology (AREA)
• General Engineering & Computer Science (AREA)
• Microbiology (AREA)
• Biochemistry (AREA)
• General Health & Medical Sciences (AREA)
• Biomedical Technology (AREA)
• Mycology (AREA)
• Molecular Biology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Physics & Mathematics (AREA)
• Biophysics (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Virology (AREA)
• Plant Pathology (AREA)
• Tropical Medicine & Parasitology (AREA)
• Botany (AREA)
• Analytical Chemistry (AREA)
• Immunology (AREA)
• Preparation Of Compounds By Using Micro-Organisms (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)

Priority Applications (8)

Applications Claiming Priority (2)

Publications (2)

Family

ID=29712012

Family Applications (3)

Family Applications After (2)

Country Status (15)

Cited By (18)

Families Citing this family (102)

Family Cites Families (31)

• 2003
  • 2003-05-30 WO PCT/US2003/016825 patent/WO2003102200A2/en not_active Ceased
  • 2003-05-30 PT PT03731489T patent/PT1513923E/pt unknown
  • 2003-05-30 WO PCT/US2003/017310 patent/WO2003102201A2/en not_active Ceased
  • 2003-05-30 UA UA20041210932A patent/UA88437C2/ru unknown
  • 2003-05-30 CA CA002488196A patent/CA2488196A1/en not_active Abandoned
  • 2003-05-30 DE DE60315028T patent/DE60315028T2/de not_active Expired - Lifetime
  • 2003-05-30 ES ES03756237.8T patent/ES2529254T3/es not_active Expired - Lifetime
  • 2003-05-30 ES ES14198669.5T patent/ES2642928T3/es not_active Expired - Lifetime
  • 2003-05-30 CA CA002487296A patent/CA2487296A1/en not_active Abandoned
  • 2003-05-30 EP EP03731489A patent/EP1513923B1/en not_active Expired - Lifetime
  • 2003-05-30 US US10/452,038 patent/US7534597B2/en not_active Expired - Lifetime
  • 2003-05-30 CN CN03817295XA patent/CN1735691B/zh not_active Expired - Fee Related
  • 2003-05-30 WO PCT/US2003/017329 patent/WO2003102152A2/en not_active Ceased
  • 2003-05-30 AT AT03731489T patent/ATE367436T1/de not_active IP Right Cessation
  • 2003-05-30 US US10/449,911 patent/US7232664B2/en not_active Expired - Lifetime
  • 2003-05-30 UA UA20041210933A patent/UA80976C2/uk unknown
  • 2003-05-30 US US10/449,978 patent/US20040029256A1/en not_active Abandoned
  • 2003-05-30 JP JP2004510437A patent/JP4318638B2/ja not_active Expired - Fee Related
  • 2003-05-30 EP EP03756356A patent/EP1513940A4/en not_active Withdrawn
  • 2003-05-30 JP JP2004510438A patent/JP2005528112A/ja active Pending
  • 2003-05-30 CA CA2487116A patent/CA2487116C/en not_active Expired - Lifetime
  • 2003-05-30 BR BR0311452-0A patent/BR0311452A/pt not_active IP Right Cessation
  • 2003-05-30 AU AU2003240481A patent/AU2003240481B8/en not_active Ceased
  • 2003-05-30 AU AU2003243366A patent/AU2003243366B2/en not_active Ceased
  • 2003-05-30 ES ES03731489T patent/ES2290466T3/es not_active Expired - Lifetime
  • 2003-05-30 AU AU2003251381A patent/AU2003251381B2/en not_active Ceased
  • 2003-05-30 BR BR0311453-8A patent/BR0311453A/pt not_active Application Discontinuation
  • 2003-05-30 BR BRPI0311517A patent/BRPI0311517A2/pt active IP Right Grant
  • 2003-05-30 EP EP14198669.5A patent/EP2878675B1/en not_active Expired - Lifetime
  • 2003-05-30 CN CNA2007101278989A patent/CN101157930A/zh active Pending
  • 2003-05-30 DK DK14198669.5T patent/DK2878675T3/en active
  • 2003-05-30 JP JP2004510394A patent/JP2005528106A/ja active Pending
  • 2003-05-30 BR BRPI0311517-8A patent/BRPI0311517B1/pt unknown
  • 2003-05-30 CN CN038172941A patent/CN1735683B/zh not_active Expired - Fee Related
  • 2003-05-30 CN CNB038172917A patent/CN100335626C/zh not_active Expired - Fee Related
  • 2003-05-30 EP EP03756237.8A patent/EP1513939B1/en not_active Expired - Lifetime
• 2004
  • 2004-11-25 ZA ZA200409529A patent/ZA200409529B/en unknown
  • 2004-11-25 ZA ZA200409531A patent/ZA200409531B/en unknown
  • 2004-11-25 ZA ZA200409530A patent/ZA200409530B/en unknown
• 2007
  • 2007-02-14 US US11/707,188 patent/US7939298B2/en active Active
• 2008
  • 2008-07-03 AU AU2008202963A patent/AU2008202963A1/en not_active Abandoned
  • 2008-08-13 JP JP2008208544A patent/JP2009000124A/ja active Pending
• 2009
  • 2009-01-12 US US12/352,133 patent/US20100137551A1/en not_active Abandoned
• 2011
  • 2011-04-01 US US13/078,128 patent/US8828707B2/en not_active Expired - Lifetime
• 2014
  • 2014-09-06 US US14/479,309 patent/US9428776B2/en not_active Expired - Lifetime

Also Published As

Similar Documents

Legal Events